Background: Advance care planning is a process of discussion and review concerning future care in the event of losing capacity. Aimed at improving the appropriateness and quality of care, it is also often considered a means of making better use of healthcare resources at the end of life. Aim: To review and summarise economic evidence on advance care planning. Design: A systematic review of the academic literature.
What is already known about the topic?
• • In the United States, there is legislation to promote advance care planning, while advance care planning is a key feature of UK policy on end-of-life care. • • Aimed at improving the appropriateness and quality of care, advance care planning is also often considered to be a means of making better use of healthcare resources at the end of life. • • Whether advance care planning can lead to cost savings or cost-effectiveness gains is the subject of ongoing debate.
What this paper adds?
• • This paper provides an overview of empirical studies, published since 1990, that report on economic outcomes associated with advance care planning. • • Research evidence is limited and heterogeneous, cost measures used are varied and no studies take a societal perspective.
• • However, the evidence suggests that advance care planning may lead to healthcare savings for some people in some circumstances.
Background
Advance care planning (ACP) is a voluntary process of discussion and review concerning future care and treatment in the event of losing capacity. ACP conversations need not be documented although usually they are. The legal and policy framework for ACP varies across countries. In the United Kingdom (UK), advance statements set out general preferences to inform best-interest decisions, while advance decisions to refuse treatment are legally binding and regulated by the Mental Capacity Act in England and Wales, with similar provision by common law in Scotland and Northern Ireland. Advance decisions may also include assigning proxy decision-making powers through lasting power of attorney (LPA) in England and Wales and power of attorney (PoA) in Scotland, while in Northern Ireland, there is no legal provision for health and welfare proxy decision-making. ACP is an important element in UK policy on end-of-life care, featuring in national end-of-life strategies for England and Wales, 1 Scotland 2 and Northern Ireland. 3 In the United States (US), advance decisions are known as advance directives (ADs), and the Patient Self-Determination Act, 1990 (PSDA) places an obligation on healthcare facilities to inform patients about their rights to make an advance healthcare directive. ADs may also include assigning durable power of attorney (DPoA). Potential benefits of ACP include care aligned with preferences, reduced misunderstandings and conflict between medical staff and families, fewer interventions of limited clinical value, earlier access to palliative care, reduced emergency hospital admissions, fewer hospital deaths and reduced anxiety and depression experienced by bereaved carers. 4, 5 Although primarily concerned with improving the appropriateness and quality of care, ACP is also often considered a means of controlling health spending and making better use of resources at the end of life. 6 Whether, however, ACP can lead to cost savings or cost-effectiveness gains in practice has been an ongoing source of debate.
Aims
Our aim was to systematically review the academic literature for empirical studies that report on economic outcomes potentially associated with ACP, published between 1990 and 2014. We included studies in which ACP forms an important and substantial element of a wider palliative care or support programme. In this article, we present and critically discuss the evidence and make proposals for future research in this area.
Methods
A systematic search of the academic literature was conducted with support from a research librarian and, following national guidance on the conduct of systematic reviews in healthcare. 7 We searched for English language, peerreviewed journal articles, 1990-2014, using relevant research databases (PubMed, ProQuest, CINAHL Plus with Full text, EconLit, PsycINFO, SocINDEX with Full Text and International Bibliography of the Social Sciences), using relevant search terms (Box 1).
For each of the selected databases, we searched for ACP terms in the title, abstract and keywords. We considered that if one of the selected terms for ACP did not occur in the abstract, title or keywords, then the study was unlikely to include ACP as a key variable in empirical research. Conservatively, however, we allowed for the cost-related terms to appear anywhere, including in the full text (with the exception of PubMed, where the search facility allowed only titles and abstracts to be searched). The initial search generated a total of 474 journal articles Implications for practice, theory or policy • • Advance care planning may lead to cost savings in some circumstances and is unlikely to be more expensive.
• • There is a need for clearer articulation of the likely mechanisms by which advance care plans can lead to reduced care costs or cost-effectiveness gains. • • Economic outcomes should be considered in the wider context of quality benefits.
Box 1. Search terms.
'advance care plan' or 'advanced care plan' or 'advance care plans' or 'advanced care plans' or 'advance care planning' or 'advanced care planning' or 'advance statement' or 'advanced statement' or 'advance statements' or 'advanced statements' or 'advance directive' or 'advanced directive' or 'advance directives' or 'advanced directives' or 'advance decision' or 'advanced decision' or 'advance decisions' or 'advanced decisions' or 'living will' or 'end of life planning' or 'end-of-life planning' or 'EOL planning' or 'end of life conversation' or 'endof-life conversation' or 'EOL conversation' or 'end of life discussion' or 'end-of-life discussion' or 'EOL discussion' or 'end of life care planning' or 'end-of-life care planning' or 'EOL care planning' or 'end of life counselling' or 'end-of-life counselling' or 'EOL counselling' or 'end of life counseling' or 'end-of-life counseling' or 'EOL counseling' AND 'cost' or 'costs' or 'spend' or 'spending' or 'expenditure' or 'savings' (following removal of 89 duplicates). In addition, we separately searched, using the cost-related terms, all PubMed articles categorised using the MeSH term, 'Advance Care Planning'. This MeSH term was introduced in 2003. It draws together published articles on ACP, which is defined as 'discussions with patients and/or their representatives about the goals and desired direction of the patient's care, particularly end-of-life care, in the event that the patient is or becomes incompetent to make decisions'. This produced 108 additional articles (after removing 131 duplicates with the original list). In total, across all searches, we identified 582 unique articles. The lead author, assisted by another researcher, reviewed titles and abstracts, and articles that turned out to be unrelated to ACP for end of life (n = 102) were removed, leaving 480 articles in total.
Abstracts and, where necessary, full papers for the 480 articles were reviewed against inclusion and exclusion criteria. Inclusion criteria were as follows: We included studies that considered ACP as part of a wider palliative care or end-of-life intervention as long as ACP formed an important and substantial element. Although we were aware that this meant that the impact of ACP could not be isolated from the rest of the intervention, we included such studies to provide a comprehensive overview of ACP-related studies reporting economic outcomes. LPoA/ PoA/ DPoA and specific medical orders (e.g. donot-resuscitate or do-not-hospitalise orders) were not searched for separately, as we were interested in these only where they were part of a broader written advance care plan or ACP process. The reasons for this were that LPoA/ PoA/ DPoA does not always involve discussion or documentation of the patient's wishes, while medical orders are often applied late, often just days before death, and not always with full discussion with either the patient or their carers or family members. 4 Where systematic and narrative reviews were identified in the search, they were reviewed with the aim of identifying further empirical studies not identified in the original search. Reference lists in included articles were also hand-searched for additional studies of relevance. One study was identified by these means. 11 A further study, from the UK independently known to the authors, was also included. 12 This appeared in the British Journal of General Practice, which was not included in the selected databases. In total, 24 full papers were reviewed two of the articles were found, on closer inspection, to solely cover DPoA or specific medical orders and were excluded. 8, 9 In one case, a study that otherwise met the criteria for inclusion was removed since, although, in principle, ACP formed an important part of the intervention (in three UK nursing homes), in practice, only 40 out of the total of 165 patients received any ACP facilitation and support (although other aspects of the programme were implemented fully). 10 The final number of included studies was 18.
Following selection, descriptive data about the 18 included studies were extracted, covering year of publication, country, type of ACP activity or intervention, target population and setting, sample and sample size, study design, economic outcome measures used and results. The level of evidence was graded according to the schema used by Brinkman-Stoppelenburg et al. 4 in their systematic review of (non-economic) outcomes associated with ACP, which were, in turn, adapted from criteria originally proposed by Higginson et al. 13 (Box 2). The results from this data extraction are presented in Table 1 . Further data, focusing on key features of definition and design, were also extracted to inform our discussion. Throughout we use US terminology (e.g. AD), reflecting the predominance of US-based research literature in this area, but when not used in reference to a specific study or otherwise stated, we intend this to include the parallel terms. When discussing US studies, the term hospice refers to palliative care provided in any setting where life expectancy is less than 6 months. When discussing UK studies, hospice refers to a UK hospice organisation, providing palliative care to people with a terminal diagnosis. Table 1 summarises the results from the review.
Results

Country
Research in this area predominantly comes from the US, following the introduction of PSDA, 1990. All but 4 of the 18 included studies are from the US, with 2 from the UK, 12,16 1 from Canada 25 and 1 from Singapore. 14 
Study design
Five of the studies use randomised designs: four randomised controlled trials (RCTs) 11, 23, 25, 26 and one cluster-RCT. 25 These evaluate different types of ACP intervention in a variety of settings, including nursing homes, 25 hospitals, 11,26 a home-based telephone counselling intervention 22 and a complex care and coordination programme delivered through Veterans Affairs Medical Centres. 23 The remaining studies are observational: 3 non-randomised controlled designs 12,14,18 and 10 natural experiments.
Study samples
The studies are based on a wide variety of populations. Three studies use data from the US Health and Retirement Study, with its nationally representative sample of older people, 15, 19, 20 while Kessler and McClellan 24 use a large 22 or by care setting, with seven of the studies based on hospital-based samples. 11, 18, 21, [26] [27] [28] [29] Some studies use samples defined by both patient characteristics and care setting, for example, patients admitted to an inpatient oncology unit in a US hospital. 21 While selective samples are appropriate for evaluating interventions specific to these populations and settings, care needs to be taken in generalising findings to individuals beyond these groups. Hospital samples, for example, are likely to over-represent those who are least able to die at home. 30 Sample sizes for the studies range from under 50 12 to around 3000 or more, 15, 19, 20, 22, 26 with one study, that looked at the economic impact of state level laws incentivising compliance with the PSDA, 1990, having a sample of over 75,000.
Definition of ACP
Of the 18 included studies, 8 are non-intervention studies, which explore the impact of ACP in general. These cover different types of ACP activity, operationalised for research in a range of ways (Table 2) . These general ACP studies, except for Zhang et al., 29 rely on secondary data sources. They, therefore, provide limited information about the process of ACP, such as when and how ACP was first initiated, whether ACP was facilitated by a trained professional or the frequency of review, factors known to influence the quality and effectiveness of ACP. 4, [31] [32] [33] The quality of ADs cannot be presumed to be always high, with Tan and Jatoi 21 noting that around a third of the 46 ADs held by patients in their study were insufficiently specific. Three studies attempt to distinguish ACP from the documenting of medical decision-making in the last weeks and days of life. Two studies specify that ADs should have been initiated prior to the index hospital admission. 21, 27 Weeks et al. 27 also gather data about when ADs were first established, finding it to be a median of 8 months prior to hospital admission. Zhang et al. 29 similarly require that end-of-life discussions with a physician should have occurred prior to study enrolment, with participants enrolled onto the study an average of 6 months prior to death.
The remaining 10 studies focus on specific interventions designed to promote ACP (Table 3 ). These are varied, but are most commonly counselling and support services, generally led by nurses and social workers, with the aims, variously, of promoting and supporting ACP, assisting in end-of-life decision-making and optimising patient-physician communication. When delivered as part of a wider intervention, these involve additional measures to identify and address unmet support needs. They may involve specialist palliative care physicians and nurses and often allow for referral to other specialist services.
Although ADs and other advance care plans are only operable when a patient loses capacity, none of the 18 studies limit their definition of ACP to such situations. Exceptionally, Weeks et al. 27 report the number of patients who lost capacity and had their AD 'activated' but note that patients with ADs do not lose capacity frequently enough for this to lead to significant healthcare savings. In practice, therefore, all of the studies assume that ACP may lead to healthcare savings for patients who do not lose capacity, but the mechanisms by which this may be achieved are not well articulated, although Weeks et al. 27 suggest that engagement in ACP may enable patients to develop and better articulate their views on care priorities or the presence of an AD in medical notes may influence the care and treatment that physicians propose.
Cost measurement
No cost-effectiveness studies, involving the systematic identification of costs and outcomes and the potential Table 2 . Operational definition of ACP in general (non-intervention) studies.
Nicholas et al. 15 A proxy report of a decedent having a treatment-limiting, written AD; United States Health and Retirement Study Nicholas et al. 19 A proxy report of a decedent having a treatment-limiting, written AD; United States Health and Retirement Study Kelley et al. 20 A proxy report of a decedent having a written AD or having engaged in an end-of-life discussion; United States Health and Retirement Study Tan and Jatoi 21 Record of an AD completed prior to hospital admission in retrospectively reviewed medical records Zhang et al. 29 Self-report during baseline interview of having had a prior discussion with their doctor about end-of-life preferences Kessler and McClellan 24 State with laws enhancing incentives for compliance with Patient Self-Determination Act (PSDA, 1990) Weeks et al. 27 Record of an AD completed prior to a terminal hospital admission in retrospectively reviewed medical records Chambers et al. 28 Record of an AD entered into patient notes within 48 h of terminal hospital admission in retrospectively reviewed medical records ACP: advance care planning; AD: advance directive.
trade-offs between these, were identified. Rather, included studies can mostly be characterised as cost savings studies, focused on identifying potential healthcare, and particularly hospital-based, cost savings. These costs are defined and measured in a wide range of different ways ( 25, 29 The use of these different cost measures produces different figures since they effectively measure different things. For example, charges made to Medicare are commonly lower than direct charges since Medicare does not cover all costs and is also able to negotiate volume discounts not available to individual health service users. 34 Charges may also be poorly aligned with underlying resource use. 34 For example, in an analysis of data from 16 A hospice in the South West of England, where preferred place of death is routinely discussed and recorded in an electronic patient record Lukas et al. 17 Optimizing Advanced Complex Illness Support (OACIS), a home-based, non-hospice palliative programme in the United States. Nurse practitioners, supported by physicians, undertake an initial 1-2 h consultation, complete a 'goals of care' transcript, assist the patient to complete an AD where appropriate and undertake follow-up visits. Nurse practitioners actively liaise with primary care physicians and managing specialists and make referrals to other services Baker et al. 12 Intensive case management and ACP undertaken with patients identified as being at increased risk of hospital admission in a Scottish general practice. An extended primary care team of case managers, a physiotherapist, an occupational therapist and care workers address unmet support needs, including through referral to other services. The programme includes rapid provision of home care and hospital-tohome transport Yoo et al. 18 Integrated palliative care service, embedded within an intensive care unit (ICU) in a United States hospital, with the aim of facilitating communications between health professionals and patients or families
Hamlet et al. 22 Telephone-based intervention in the United States, where each patient has a designated nurse trained in end-of-life counselling. Sessions cover counselling about ADs, choice of aggressive versus palliative care and hospice enrolment. The nurse also facilitates interaction with physicians and hospice agencies and makes other referrals as required Gade et al. 11 Interdisciplinary palliative care service (IPCS) teams, in three United States hospitals, including a palliative care physician, palliative care nurse, hospital social worker and chaplain. The teams assess patients' needs for symptom management, psychosocial and spiritual support, end-of-life planning and post-discharge care and organise relevant follow-up and referrals. The discharge plan is communicated to primary care physicians via an electronic patient record Engelhardt et al. 23 United States-based Advanced Illness Coordinated Care Program (AICCP), delivered in a series of healthcare settings over six sessions by a care coordinator. Sessions may cover a wide range of issues including ACP, completion of ADs, health literacy, preparing questions for physician appointments, care coordination and referrals, addressing emotional and psychological needs, family communication and so on Molloy et al. 25 Let Me Decide AD programme in three Canadian nursing homes, involving education for hospital and nursing home staff about ADs and facilitation of ACP with patients and/or families of nursing home residents Teno et al. 26 The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT), conducted in five teaching hospitals in the United States, including an intervention in which trained nurses had multiple contacts with patients, families, physicians and hospital staff to elicit preferences, improve understanding of outcomes and facilitate ACP and physician-patient communication ACP: advance care planning; CARE: Caring Actions Responding to Elders; AD: advance directive.
one UK hospital trust, Blunt and Bardsley 35 found that costs for delivering services were often very different from the tariff price paid by NHS commissioners, with only 17% of patients incurring costs that fell within 10% of the tariff price. The most appropriate measure, therefore, depends on what it is intended exactly to measure and the economic perspective taken. Hamlet et al. 22 evaluate an intervention explicitly designed to identify cost savings to Medicare. Commonly, however, the economic perspective taken is not made explicit in the included studies, although is implied in the cost measures chosen, which, in all of the studies, are limited to healthcare costs. Eight of the studies include community-based as well as hospital costs, 11, 14, 15, 19, 20, 22, 23, 24 although the range of included services varies and it is often unclear whether all possible healthcare services are covered. Of the studies, 10 include only, or primarily, hospital costs. 12, [16] [17] [18] [25] [26] [27] [28] [29] Since reduced inpatient hospital care is likely to require substitution with communitybased health and palliative care services, [36] [37] [38] [39] studies that focus only on hospital costs will fail to identify impacts on these wider service costs.
None of the studies takes a societal perspective, with all non-healthcare costs omitted from analyses. However, Table 4 . Operational definition of costs.
General (non-intervention) studies Nicholas et al. 15 Medicare expenditure in last 6 months of life Nicholas et al. 19 Medicare expenditure in last 6 months of life Kelley et al. 20 Medicare expenditure in last 6 months of life Tan and Jatoi 21 Total hospital costs using accounting costs adjusted for age at death and length of stay Zhang et al. 29 Hospital costs for 1 week before death, estimated using the National (Nationwide) Inpatient Sample, based on a national 20% random sample of hospital discharges. Kessler and McClellan 24 Total Medicare claims, including co-payments and deductibles, for last month of life Weeks et al. 27 Physician and hospital charges for terminal admission adjusted by diagnosis-related groups Chambers et al. 28 Hospital charges adjusted by a range of factors, including clinical and demographic factors
Intervention studies Teo et al. 14 Per-patient nursing home costs are derived by dividing total budget by number of patient days. Hospital, primary and other healthcare costs are based on average charge per day or unit cost, provided by the nursing home group finance department. Intervention costs are estimated using fixed costs along with estimated activity multiplied by hourly staff costs. All estimates cover the last 3 months of life Abel et al. 16 Actual costs of hospital treatment in last year of life adjusted for length of stay and complexity of care as per national agreement Lukas et al. 17 Total and variable hospital accounting costs, estimated for the period 18 months pre-enrolment and compared to the period 18 months post-enrolment Baker et al. 12 Costs of unplanned hospitalisations are calculated using an NHS local patient-level information and costing system (PLICS), with data gathered for 3 months prior to death for decedents and 12 months prior to, and following, the introduction of the intervention for survivors Yoo et al. 18 Total Medicare and Medicaid charges for index hospital admission Hamlet et al. 22 Total Medicare expenditure in last 6 months of life, excluding hospice care
Gade et al. 11 Health service costs calculated using accounting costs, based on agreed rate structure/contract rates, and covering costs for emergency department, clinic, hospital outpatient, home health visits, hospital readmissions, skilled nursing facility admissions and pharmacy. Intervention costs estimated using staff time and wages Engelhardt et al. 23 Cost data for health services from participating Veterans Affairs Medical Centre cost records. Intervention costs calculated using contact time and salary for care coordinators and relevant overhead costs Molloy et al. 25 Different healthcare interventions and services received by residents (covering hospital treatment, emergency department, physician consultations, outpatient services, diagnostic procedures, surgical operations and pharmacy) were monitored and the costs of these estimated using unit costs derived from the Government-led Ontario Case Costing Project and the Ontario fee schedule, Ontario Ministry of Health price list and the Ontario Drug Benefit formulary Teno et al. 26 Hospital charges for index admission, adjusted by Therapeutic Intensity Scale Score (TISS) and length of stay NHS: National Health Service.
fewer hospitalisations and hospital deaths are likely to have impacts for unpaid family and other carers. 20, 38, [40] [41] [42] These may include negative impacts, for example, on carers' mental and physical health or their employment and finances 43 and on the total amount of unpaid care provided. 36, 41 However, there may also be positive impacts, with ACP found to be associated, for example, with less depression and anxiety for carers. 31, 44 Reduced hospitalisation has also been found to be associated with increased use of social care services in the UK, 45 although a follow-up study suggests these costs are unlikely to be high. 46 Finally, the primary purpose of ACP is to improve people's quality of life and reduce avoidable distress. In economic evaluations, it is increasingly common to use a health-related quality of life measure to generate estimates of quality-adjusted life years (QALY), 47, 48 with the Palliative Care Yardstick (PalY) promoted by some as a potential alternative measure. [49] [50] [51] [52] However, none of the studies include such measures. The limited reach of cost measurement is explicitly acknowledged by Hamlet at al. 22 and Weeks et al. 27 Intervention costs are also not always reported. Only 4 of the 10 intervention studies report per-patient intervention costs, 11, 14, 23, 25 although Lukas et al. 17 provide staffing and caseload information and Baker et al. 12 provide an overall cost for the additional staffing required for the intervention. In the general ACP studies, we do not know whether or not patients received ACP facilitation, and no costs for facilitation are included. The studies also vary in the period over which cost savings are measured, ranging from the last year 16 to the last week of life, 29 or not anchored by death at all, as in Baker et al., 12 where costs are measured for a year post-intervention. 12 
Controlling for confounding variables
Ethical and practical concerns mean that RCTs in endof-life care research are difficult to implement. 53, 54 Nonetheless, five studies 11, 22, 23, 25, 26 use randomised designs. The remaining studies take steps, using multivariate regression analyses, propensity score matching or other statistical approaches, to control for confounding variables. Kelley et al. 20 in their analysis of data from the Health and Retirement Study include age, gender, ethnicity, sex, education level, net worth, religiosity, self-rated health, having relatives nearby, marital status, residential status, type of non-Medicare insurance coverage (Medicaid, Medigap or Veterans Administration), functional status, diagnosis and a range of regional variables. Other studies using Health and Retirement Study data additionally include factors such as cognitive status, comorbidities and alternative regional variables such as nursing home capacity. 15, 19 Other observational studies control for a similar range of demographic and risk-related variables. 14, 18, 21, [27] [28] [29] In the UK, Baker et al. 12 selected intervention and control groups using a predictive model for identifying those at risk of hospitalisation and matched patients in the two groups. However, the control group was located nearby so the authors were unable to control for factors affecting the area-wide health system and, in practice, because so few patients died over the course of the study, the sample of decedents was effectively unmatched. Abel et al. 16 in a study using a selective sample of primarily cancer patients under the care of a UK hospice, control for fewest factors, indicating only that the age and gender profile of the ACP and non-ACP group were similar.
Critically, in most of the observational studies, patient self-selection remains uncontrolled for and an important risk to validity, since it is possible that patients engaging in ACP may differ in their attitudes to dying or in their perception of disease curability. They may also have doctors who favour less aggressive care or carers who are more supportive of the withdrawal of curative care in the late stages of illness. 27 The work by Zhang et al., 29 who found a positive association between ACP and hospital cost savings in the last week of life, is the only study to gather primary data in interviews with patients and families, using this to control for illness acknowledgement and treatment preferences. The interview with the patients and families follow rather than precede the occurrence of ACP (a prior discussion about end-of-life preferences with a physician), but are still conducted an average of 6 months before death.
Economic effects of ACP
Study findings are mixed, with little evidence of results being influenced by whether the study is a general ACP or intervention study, the research design, sample size or setting. For example, of the eight studies that explore the impact of ACP in general, just over half (5) report a statistically significant association between ACP and healthcare savings. 15, 19, [27] [28] [29] Of the 10 intervention studies, exactly half (5) report a statistically significant association between the intervention and healthcare savings. 11, 14, 17, 22, 25 With regard to research design, looking just at the five RCTs, just over half (3) report a statistically significant association between ACP and reduced healthcare costs, 11, 22, 25 while just over half (7) of the 13 observational studies found a statistically significant association between ACP and reduced healthcare costs. 14, 15, 16, 19, [27] [28] [29] There is also no apparent relationship between positive findings and sample size, although two studies that found no association had relatively small sample sizes and may have been under-powered. 21, 23 Both nursing home studies found positive results; 14, 25 however, there was no clear pattern between positive results and other care-settings.
The level and source of cost savings
Because of the different measures, cost savings figures are not comparable between studies. However, reported savings figures ranged (unadjusted for inflation) from US$64,827 for the terminal hospitalisation of decedents in a US hospital, 28 through US$56,700 in total healthcare costs over 6 months for high-cost, low-income Medicare beneficiaries 22 and US$11,500 over last 6 months of life for decedents with dementia living in the community, 15 to US$1041 in hospital costs over last week of life, for decedents with cancer. 29 There is limited information provided amongst the included studies about the source of cost savings. However, ll of the studies with positive results (with the exception of Teo et al. 14 and Hamlet et al. 22 which measured only economic outcomes) found corresponding reductions in a range of associated non-economic outcomes. These covered reductions in hospital death and intensive care unit (ICU) use; 15 hospitalisations, length of stay and 30-day re-admissions; 17 hospital deaths; 19 ICU admissions and aggressive treatments; 29 ICU use for patients re-admitted after the index hospitalisation; 11 hospitalisations for nursing home residents; 25 ICU use and major surgical treatments; 27 and ICU use, reduced length of stay and billable procedures. 28 The association between ACP and cost savings was less clear in the two UK studies. However, Baker et al. 12 found that ACP was associated with reduced hospitalisations and length of hospital stay for a small sample of decedents, albeit compared with an effectively unmatched control group, and Abel et al. 16 found that ACP was associated with reduced length of hospital stay in the last year of life, although not with a reduced number of hospital admissions.
Conclusion
Strengths and limitations
Our review covers 24 years, capturing research dating back to the introduction of the PSDA (1990) in the US. It is wide ranging, covering all populations and settings, and provides an overview of the range and heterogeneity of economic studies in this area. However, the review is also subject to a number of limitations. The small number of relevant studies, the lack of cost-effectiveness studies, various methodological limitations and the fact that studies were highly heterogeneous limit our ability to draw firm conclusions about the economic outcomes associated with ACP. It was also difficult to find an adequate search strategy given the diversity of the literature. Two studies were identified outside of the main search, one through a review of references and one independently known to the authors. It is also possible that we missed some relevant articles that did not refer to ACP in the abstract. However, although the supplementary search of PubMed based on the MeSH term 'advance care planning' identified further studies, none of these were included amongst the final 18 relevant studies, providing some confidence that our initial search strategy was sufficiently rigorous. We also included studies where ACP was a significant part of a wider intervention, thus overlapping with a broader literature on palliative care and end-of-life interventions.
Summary and conclusion
Overall, evidence on the economic implications of ACP is limited and equivocal. However, there is no evidence that suggests ACP is likely to be more costly and the literature includes some well-conducted studies that find a statistically significant association between ACP (or interventions involving ACP facilitation as a significant element) and healthcare savings. In particular, there is evidence that ACP is associated with healthcare savings for some people in some circumstances, including people living in nursing homes, 14, 25 with high support needs and low income, 22 living with dementia in the community 15 and living in a high-spending healthcare region. 19 The vulnerability of observational studies to selection bias is a significant challenge for research in this area. Brinkman-Stoppelenburg et al., 4 in their systematic review of the (non-economic) effects of ACP on end-oflife care, consequently call for more experimental designs, with Halpern and Emanuel 55 proposing cluster RCT designs, to address some of the ethical challenges associated with experimental research. However, our review suggests that the challenges are not just those of managing selection biases, although this is important. The need to better understand the mechanisms linking ACP to healthcare savings and the potential for identifying and targetting populations and circumstances with the greatest potential for cost-effectiveness gains suggest a need for more mixed methods research. 53 This could include the use of realist approaches, which aim to make explicit and test causal pathways and are particularly suitable for evaluating complex interventions. 56 There is also a need to ensure that the design and implementation of ACP interventions in practice are effective, 57 suggesting a role for developmental research, implementation research and process evaluation.
Finally, the identified studies focus exclusively on healthcare cost savings, potentially fostering a view that interest in ACP is driven by a search for short-term cost savings. 55 Research into the economic implications of ACP would benefit from a longer-term perspective, with an emphasis not just on costs but also on cost-effectiveness, with more research undertaken to understand the impact on unpaid carers, greater consideration given to substitute community-based care and efforts made to reflect important quality of life benefits. While it can appear that policy-makers and commissioners are interested in making cost savings, what they are generally trying to do is contain costs within the constraints of available budgets and allocate resources in ways that are efficient and equitable. It is important to develop further evidence on the economic implications of ACP to support policy-makers and commissioners in this task and to help ensure appropriate investment in end-of-life care services.
